An Unusual Presentation of Purine Nucleoside Phosphorylase Deficiency Mimicking Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome
Overview
Authors
Affiliations
Background: Systemic juvenile idiopathic arthritis (sJIA) is an inflammatory condition that presents with fever, rash and arthritis. At onset systemic features are predominant and the diagnosis may be a challenge. Secondary hemophagocytic lymphohistiocytosis (sHLH) forms may be associated with different disorders, including rheumatic diseases, and this form is called macrophage activation syndrome (MAS). CXCL9 levels, a chemokine induced by IFNγ, are significantly elevated in patients with sHLH or MAS and are correlated with laboratory features of disease activity. High levels of IL-18 have been reported in patients with MAS during sJIA, as well as in some patients with sHLH and IL-18 is indeed known to induce IFNγ production.
Findings: We report a patient with a clinical presentation highly suggestive for systemic juvenile idiopathic arthritis (sJIA) onset complicated by MAS, and was later diagnosed with purine nucleoside phosphorylase (PNP)-deficiency with HLH. Some unusual features appeared when HLH was controlled and further investigations provided the correct diagnosis. Serum CXCL9 and IL-18 levels were found markedly elevated at disease onset, during the active phase of MAS and decreased progressively during the course.
Conclusion: The reported case underlines the potential difficulties in discriminating sJIA from other causes of systemic inflammation. Furthermore, this supports the notion that especially in young children with a sJIA-like disease other mimicking conditions should be actively sought for. CXCL9 and IL-18 levels suggested that patients with PNP-deficiency may have a subclinical activation of the IFNγ pathway and indeed they are predisposed to develop sHLH.
Alizadeh Z, Badalzadeh M, Heydarlou H, Shakerian L, Mahlooji Rad M, Zandieh F Arch Iran Med. 2024; 26(12):712-716.
PMID: 38431953 PMC: 10915924. DOI: 10.34172/aim.2023.105.
Biological and clinical roles of IL-18 in inflammatory diseases.
Landy E, Carol H, Ring A, Canna S Nat Rev Rheumatol. 2023; 20(1):33-47.
PMID: 38081945 DOI: 10.1038/s41584-023-01053-w.
Inborn Errors of Purine Salvage and Catabolism.
Camici M, Garcia-Gil M, Allegrini S, Pesi R, Bernardini G, Micheli V Metabolites. 2023; 13(7).
PMID: 37512494 PMC: 10383617. DOI: 10.3390/metabo13070787.
Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases.
Shimizu M, Takei S, Mori M, Yachie A Front Immunol. 2022; 13:951535.
PMID: 36211331 PMC: 9537046. DOI: 10.3389/fimmu.2022.951535.